Ftse Mib
34.650,95
0,91%
DAX
18.772,85
0,50%
S&P 500
5.221,57
0,14%
NASDAQ
16.334,68
-0,07%
Bitcoin
60.529,17
-4,00%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Epistem (EHP) Epistem (EHP) Notizie

EHP

Epistem (EHP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EHP
DataOraFonteTitoloSimboloCompagnia
31/08/202108:00RNS Non-RegulatoryGenedrive PLC New Genedrive system readied for AIHL launchLSE:EHPEpistem
23/04/202108:00RNS Non-RegulatoryGenedrive PLC Excellent performance data for Genedrive(R) HCV testLSE:EHPEpistem
03/03/202108:00RNS Non-RegulatoryGenedrive PLC Antibiotic Induced Hearing Loss updateLSE:EHPEpistem
01/03/202108:00RNS Non-RegulatoryGenedrive PLC Investor PresentationLSE:EHPEpistem
17/02/202108:00RNS Non-RegulatoryGenedrive PLC First US shipments of Genedrive(R) 96 SARS-CoV-2 KitLSE:EHPEpistem
03/12/202008:00RNS Non-RegulatoryGenedrive PLC AIHL hospital study completionLSE:EHPEpistem
20/11/202008:00RNS Non-RegulatoryGenedrive PLC High clinical accuracy in India studyLSE:EHPEpistem
10/07/202008:01RNS Non-RegulatoryGenedrive PLC New Genedrive(R) 96 Exporter softwareLSE:EHPEpistem
03/12/201908:01RNS Non-RegulatoryGenedrive PLC AIHL assay kit demonstrates high clinical accuracyLSE:EHPEpistem
07/10/201908:00RNS Non-RegulatoryGenedrive PLC NHS Ethics approval for use of AIHL test in trialsLSE:EHPEpistem
29/11/201808:01RNS Non-RegulatoryGenedrive PLC AbbVie to use HCV assay in studyLSE:EHPEpistem
08/08/201808:01RNS Non-RegulatoryGenedrive PLC genedrive partners with FIND to evaluate HCV testLSE:EHPEpistem
18/04/201808:01RNS Non-RegulatoryGenedrive PLC genedrive plc to Present at the UK Investor ShowLSE:EHPEpistem
10/04/201808:01RNS Non-RegulatoryGenedrive PLC Publication of Genedrive Performance Data in GutLSE:EHPEpistem
03/04/201808:01RNS Non-RegulatoryGenedrive PLC Genedrive® Hepatitis C test in Asia PacificLSE:EHPEpistem
13/03/201808:02RNS Non-RegulatoryGenedrive PLC Commercial sales of Genedrive® HCV ID Kit beginLSE:EHPEpistem
18/01/201812:59RNS Non-RegulatoryGenedrive PLC Hardman Res: Hep-C point-of-care test launchedLSE:EHPEpistem
16/01/201808:00RNS Non-RegulatoryGenedrive PLC First Successful Field Evaluation of HCV AssayLSE:EHPEpistem
13/12/201708:15RNS Non-RegulatoryGenedrive PLC Hardman Research: Remodelled for growthLSE:EHPEpistem
23/10/201708:00RNS Non-RegulatoryGenedrive PLC Launches Genedrive® Hepatitis C test in AfricaLSE:EHPEpistem
11/04/201708:01RNS Non-RegulatoryGenedrive PLC Hep C data presentation at EASLLSE:EHPEpistem
16/01/201708:00RNS Non-RegulatoryGenedrive PLC Update on US Department of Defense ProgrammeLSE:EHPEpistem
17/11/201608:01RNS Non-RegulatoryGenedrive PLC CE-IVD Certification for Human Genotyping TestLSE:EHPEpistem
10/08/201608:00RNS Non-RegulatoryGenedrive PLC Genedrive Assay used in STOP-HCV-1 Clinical TrialLSE:EHPEpistem
25/07/201609:51Alliance NewsAlliance NewsEpistem Changes Name To Genedrive To Better Reflect Company FocusLSE:EHPEpistem
25/07/201608:00UK RegulatoryGenedrive PLC Re change of name, TIDM and website addressLSE:EHPEpistem
14/07/201616:56UK RegulatoryEpistem Holdings plc Holding(s) in CompanyLSE:EHPEpistem
14/07/201609:19UK RegulatoryEpistem Holdings plc Director/PDMR ShareholdingLSE:EHPEpistem
12/07/201618:31Alliance NewsAlliance NewsCORRECT: DIRECTOR DEALINGS: Epistem Directors Take Part In PlacingLSE:EHPEpistem
12/07/201614:08Alliance NewsAlliance NewsDIRECTOR DEALINGS: Epistem Holdings Directors Take Part In PlacingLSE:EHPEpistem
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EHP

La tua Cronologia

ASX
EXTOC
Excite Technology Services
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network